Your browser doesn't support javascript.
loading
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas, Elena; Lampaki, Sofia; Koliou, Georgia-Angeliki; Koumarianou, Anna; Levva, Sofia; Vagionas, Anastasios; Christopoulou, Athina; Laloysis, Athanasios; Psyrri, Amanda; Binas, Ioannis; Mountzios, Giannis; Kentepozidis, Nikolaos; Kotsakis, Athanassios; Saloustros, Emmanouil; Boutis, Anastasios; Nikolaidi, Adamantia; Fountzilas, George; Georgoulias, Vassilis; Chrysanthidis, Miltiadis; Kotteas, Elias; Vo, Henry; Tsiatas, Marinos; Res, Eleni; Linardou, Helena; Daoussis, Dimitrios; Bompolaki, Iliada; Andreadou, Anna; Papaxoinis, George; Spyratos, Dionisios; Gogas, Helen; Syrigos, Konstantinos N; Bafaloukos, Dimitrios.
Afiliación
  • Fountzilas E; Second Department of Medical Oncology, Euromedica General Clinic of Thessaloniki, Gravias 5, 54645, Thessaloniki, Greece. elenafou@gmail.com.
  • Lampaki S; European University Cyprus, Engomi, Cyprus. elenafou@gmail.com.
  • Koliou GA; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Koumarianou A; Department of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece.
  • Levva S; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Vagionas A; Department of Medical Oncology, Bioclinic of Thessaloniki, Thessaloniki, Greece.
  • Christopoulou A; Department of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece.
  • Laloysis A; Oncology Department, General Hospital of Kavala, Kavala, Greece.
  • Psyrri A; Medical Oncology Unit, S. Andrew Hospital, Patras, Greece.
  • Binas I; Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Mountzios G; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Kentepozidis N; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  • Kotsakis A; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece.
  • Saloustros E; Department of Medical Oncology, 251 Airforce General Hospital, Athens, Greece.
  • Boutis A; Department of Oncology, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.
  • Nikolaidi A; Department of Oncology, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.
  • Fountzilas G; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece.
  • Georgoulias V; Oncology Department, MITERA Hospital, Athens, Greece.
  • Chrysanthidis M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kotteas E; Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Vo H; German Oncology Center, Limassol, Cyprus.
  • Tsiatas M; University of Crete, Rethymnon, Greece.
  • Res E; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  • Linardou H; Oncology Unit GPP, Sotiria General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Daoussis D; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bompolaki I; Department of Oncology, Athens Medical Center, Athens, Greece.
  • Andreadou A; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Papaxoinis G; Fourth Oncology Department, Metropolitan Hospital, Piraeus, Greece.
  • Spyratos D; Department of Internal Medicine, Division of Rheumatology, University of Patras Medical School, Patras University Hospital, Rion, Greece.
  • Gogas H; Oncology Department, General Hospital of Chania, Crete, Greece.
  • Syrigos KN; Third Department of Medical Oncology, Theagenio Hospital, Thessaloniki, Greece.
  • Bafaloukos D; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
Cancer Immunol Immunother ; 71(2): 327-337, 2022 02.
Article en En | MEDLINE | ID: mdl-34164709
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Grecia